Literature DB >> 14712236

Proteasome-dependent dispersal of PML nuclear bodies in response to alkylating DNA damage.

Lindus A Conlan1, Carolyn J McNees, Jörg Heierhorst.   

Abstract

Promyelocytic leukemia protein (PML) nuclear bodies (NBs) are present in variable number in most human cell types and have been linked to various cellular functions, including roles as depots for DNA repair proteins. Here, we show that treatment of human cells with DNA methylating agents leads to redistribution of PML from NBs to a diffuse nuclear localization. Biochemically, this correlates with a specific reduction of PML levels in the nuclear matrix fraction without affecting total PML levels. Similar results were obtained for the other major PML NB component, the Sp100 protein, indicating that DNA methylating agents lead to a general disassembly of PML NBs. Similar to the dispersal of PML NBs in response to some viral infections, PML redistribution after DNA damage was inhibited by the proteasome inhibitor MG132. We propose that the regulated dispersal of PML NBs may facilitate the enhanced release of DNA repair proteins from NB depots in order to respond adequately to extensive DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14712236     DOI: 10.1038/sj.onc.1207119

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication.

Authors:  Kareem N Mohni; Adam S Mastrocola; Ping Bai; Sandra K Weller; Christopher D Heinen
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage.

Authors:  Carolyn J McNees; Lindus A Conlan; Nora Tenis; Jörg Heierhorst
Journal:  EMBO J       Date:  2005-06-02       Impact factor: 11.598

3.  Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Wen-Hung Wang; Chung-Wen Kuo; Li-Kwan Chang; Chen-Chia Hung; Tzu-Hsuan Chang; Shih-Tung Liu
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  The autophagic protein LC3 translocates to the nucleus and localizes in the nucleolus associated to NUFIP1 in response to cyclic mechanical stress.

Authors:  Myoung Sup Shim; April Nettesheim; Joshua Hirt; Paloma B Liton
Journal:  Autophagy       Date:  2019-09-16       Impact factor: 16.016

5.  ND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection.

Authors:  Roger D Everett; Jill Murray
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 6.  Nuclear organization in genome stability: SUMO connections.

Authors:  Shigeki Nagai; Niloofar Davoodi; Susan M Gasser
Journal:  Cell Res       Date:  2011-02-15       Impact factor: 25.617

7.  Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen.

Authors:  Xiaoyi V Hu; Tânia M A Rodrigues; Haiyan Tao; Robert K Baker; Loren Miraglia; Anthony P Orth; Gary E Lyons; Peter G Schultz; Xu Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

8.  Telomeric DNA mediates de novo PML body formation.

Authors:  Anneke K Brouwer; Joost Schimmel; Joop C A G Wiegant; Alfred C O Vertegaal; Hans J Tanke; Roeland W Dirks
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

9.  Ubiquitin-specific Protease 11 (USP11) Deubiquitinates Hybrid Small Ubiquitin-like Modifier (SUMO)-Ubiquitin Chains to Counteract RING Finger Protein 4 (RNF4).

Authors:  Ivo A Hendriks; Joost Schimmel; Karolin Eifler; Jesper V Olsen; Alfred C O Vertegaal
Journal:  J Biol Chem       Date:  2015-05-12       Impact factor: 5.157

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.